Protocol No
ANTHOS-ANT-007
Phase
III
Summary
This project is being done to see if patients taking the study drug Abelacimab have fewer bleeding events compared to those taking Apixaban for the treatment of venous thromboembolism (VTE) while receiving treatment for cancer.
Description
A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE (ASTER)
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL
Categories
Cancer,
Hematologic/Blood Related Cancers,
Other Respiratory,
Lung,
Esophagus,
Other Skin,
Melanoma, Skin,
Other Urologic,
Bladder,
Prostate,
Kidney,
Lip, Oral Cavity and Pharynx,
Larynx,
Other Gynecologic,
Uterine,
Ovary,
Cervix,
Other Gastrointestinal,
Stomach,
Pancreas/Liver,
Esophagus,
Colorectal,
Thoracic Cancers,
Sarcoma,
Skin Cancers,
Prostate and Urologic Cancers,
Head and Neck Cancers,
Gynecologic Cancers,
Gastrointestinal Cancers,
Eye/Orbital Cancers,
Endocrine Cancers,
Breast Cancers,
Brain and Spine Cancers
ClinicalTrials.gov